Cargando…
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
BACKGROUND: Hydroxychloroquine (HCQ) and azithromycin (AZT) have been proposed for COVID-19 treatment. Data available in the literature reported a potential increased risk of fatal arrhythmias under these therapies. The aim of this study was to assess the effects of these drugs on QT interval and ou...
Autores principales: | Bernardini, Andrea, Ciconte, Giuseppe, Negro, Gabriele, Rondine, Roberto, Mecarocci, Valerio, Viva, Tommaso, Santini, Francesca, de Innocentiis, Carlo, Giannelli, Luigi, Witkowska, Ewa, Locati, Emanuela Teresina, Castelvecchio, Serenella, Marrocco-Trischitta, Massimiliano M., Vicedomini, Gabriele, Menicanti, Lorenzo, Pappone, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501148/ https://www.ncbi.nlm.nih.gov/pubmed/32956782 http://dx.doi.org/10.1016/j.ijcard.2020.09.038 |
Ejemplares similares
-
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death
por: Pappone, Carlo, et al.
Publicado: (2023) -
Brugada syndrome genetics is associated with phenotype severity
por: Ciconte, Giuseppe, et al.
Publicado: (2020) -
Sudden death of a patient with epilepsy: When Brugada syndrome mimicry can be fatal
por: Negro, Gabriele, et al.
Publicado: (2021) -
Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm
por: Pappone, Carlo, et al.
Publicado: (2021) -
Genotype–Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene
por: Monasky, Michelle M., et al.
Publicado: (2019)